The NHS plans to roll out Mounjaro, a weight-loss jab that can help users lose up to a quarter of their body weight, making it more potent than Ozempic. Anna Magee explains how to choose the best opti ...

Glucagon-like peptide 1 receptor agonists, more commonly known as GLP-1 medications, have dominated headlines for their ...

Does drinking water help you lose weight? Believe it or not, it can. While this might sound too good to be true, there’s some ...

Wegovy and Zepbound are still hard to get. Knockoff versions from Noom, Ro, and others are filling in the gaps.

Cramer remains steadfast on Eli Lilly and Company (NYSE:LLY) as per Mad Money’s episode on September 30. Despite there being ...

In real-world settings multiple factors contribute to non-persistence, including adverse effects, high cost-sharing and ...

Market-beating returns could be on the way for patient investors in these two up-and-coming healthcare growth stocks.

Finding the right solution for weight loss can feel overwhelming, especially with so many options available. While ...

Kourtney Kardashian’s vitamin and supplement brand Lemme launched GLP-1 daily capsules in mid-September. For $90 a month, the ...

Noom Appoints Olcott to Advance Noom Med Programming Following Newly Launched GLP-1Rx SolutionNEW YORK, Oct. 01, 2024 (GLOBE ...